Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
April 28, 2006
Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target
Curtis R Chong, David Z Qian, Fan Pan, et al.
Cancer Research
|
September 18, 2004
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584
David Z Qian, Xiaofei Wang, Sushant K Kachhap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells
Anne Myrthue, Brooks L S Rademacher, Janet Pittsenbarger, et al.
Journal of Medicinal Chemistry
|
May 30, 2015
Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity
Fuchun Xie, Bingbing X Li, Alina Kassenbrock, et al.
Cancer Research
|
September 5, 2006
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha
David Z Qian, Sushant K Kachhap, Spencer J Collis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors
Henk M W Verheul, Brenda Salumbides, Karen Van Erp, et al.
The Journal of Biological Chemistry
|
August 22, 2012
HIF1α protein stability is increased by acetylation at lysine 709
Hao Geng, Qiong Liu, Changhui Xue, et al.
The Prostate
|
December 10, 2025
Prostate Cancer Cells With the AR-Low and EMT-High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors
Hyun-Kyung Ko, Rebecca L Foertsch, Kasen Shi, et al.
The Prostate
|
January 15, 2005
In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells
David Z Qian, Mingqiang Ren, Yongfeng Wei, et al.
The Prostate
|
April 11, 2025
Understanding Enzalutamide-Resistance Based on a Functional Single-Cell Approach
Changhui Xue, Hyun-Kyung Ko, Kasen Shi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
April 28, 2006
Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target
Curtis R Chong, David Z Qian, Fan Pan, et al.
Cancer Research
|
September 18, 2004
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584
David Z Qian, Xiaofei Wang, Sushant K Kachhap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells
Anne Myrthue, Brooks L S Rademacher, Janet Pittsenbarger, et al.
Journal of Medicinal Chemistry
|
May 30, 2015
Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity
Fuchun Xie, Bingbing X Li, Alina Kassenbrock, et al.
Cancer Research
|
September 5, 2006
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha
David Z Qian, Sushant K Kachhap, Spencer J Collis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors
Henk M W Verheul, Brenda Salumbides, Karen Van Erp, et al.
The Journal of Biological Chemistry
|
August 22, 2012
HIF1α protein stability is increased by acetylation at lysine 709
Hao Geng, Qiong Liu, Changhui Xue, et al.
The Prostate
|
December 10, 2025
Prostate Cancer Cells With the AR-Low and EMT-High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors
Hyun-Kyung Ko, Rebecca L Foertsch, Kasen Shi, et al.
The Prostate
|
January 15, 2005
In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells
David Z Qian, Mingqiang Ren, Yongfeng Wei, et al.
The Prostate
|
April 11, 2025
Understanding Enzalutamide-Resistance Based on a Functional Single-Cell Approach
Changhui Xue, Hyun-Kyung Ko, Kasen Shi, et al.
Page
of 5